SCHEMBL24271804

SCHEMBL24271804

Cc1nc(CO)sc1-c1cccc(-c2cc(C(=O)O)cs2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ MEN1 O00255 7/20 0.39
▸ KMT2A Q03164 7/20 0.39
▸ MAPT P10636 6/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ ATM Q13315 1/20 0.39
▸ PIK3CG P48736 2/20 0.39
▸ GPR52 Q9Y2T5 1/20 0.38
▸ PI4KB Q9UBF8 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.36
▸ GAA P10253 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ DAO P14920 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ CLK1 P49759 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26633668 0.85 BPGM (0.50) POLBTDP1L3MBTL1MEN1KMT2A
SCHEMBL24272257 0.78 MEN1 (0.38) POLBTDP1L3MBTL1MEN1KMT2A
SCHEMBL26750463 0.77 GRM5 (0.34) POLBTDP1L3MBTL1MEN1KMT2A
SCHEMBL24272272 0.75 BPGM (0.49) MEN1KMT2AMAPTALDH1A1GPR52
SCHEMBL24271806 0.74 BPGM (0.41) MAPTGPR52NPSR1GAAKDM4E
SCHEMBL24271914 0.71 KDM4E (0.43) L3MBTL1MAPTGPR52NPSR1GAA
SCHEMBL24271769 0.68 BPGM (0.52) POLBTDP1L3MBTL1MEN1KMT2A
SCHEMBL13992625 0.67 KDM5C (0.49) POLBL3MBTL1MAPTALDH1A1GAA
SCHEMBL24271932 0.67 BPGM (0.63) POLBMEN1KMT2AMAPTPIK3CG
SCHEMBL26750493 0.67 BPGM (0.53) POLBTDP1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348450-A1 CARBOXYLIC ACID-CONTAINING COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE GENZYME CORPORATION 2023-11-02 — — US disclosed
US-20230348450-A1 CARBOXYLIC ACID-CONTAINING COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE GENZYME CORPORATION 2023-11-02 — — US disclosed
WO-2022056447-A1 CARBOXYLIC ACID-CONTAINING COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE GENZYME CORPORATION (US) 2022-03-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348450-A1 CARBOXYLIC ACID-CONTAINING COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE BPGM, PGAM1, PGM2 POLB 150/4885TDP1 1504/4885L3MBTL1 828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback